These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 20885964)
1. Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts. Nishino K; Toyoda M; Yamazaki-Inoue M; Makino H; Fukawatase Y; Chikazawa E; Takahashi Y; Miyagawa Y; Okita H; Kiyokawa N; Akutsu H; Umezawa A PLoS One; 2010 Sep; 5(9):e13017. PubMed ID: 20885964 [TBL] [Abstract][Full Text] [Related]
2. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Doi A; Park IH; Wen B; Murakami P; Aryee MJ; Irizarry R; Herb B; Ladd-Acosta C; Rho J; Loewer S; Miller J; Schlaeger T; Daley GQ; Feinberg AP Nat Genet; 2009 Dec; 41(12):1350-3. PubMed ID: 19881528 [TBL] [Abstract][Full Text] [Related]
3. Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray. He W; Kang X; Du H; Song B; Lu Z; Huang Y; Wang D; Sun X; Yu Y; Fan Y PLoS One; 2014; 9(9):e108350. PubMed ID: 25250679 [TBL] [Abstract][Full Text] [Related]
5. Derivation of novel human ground state naive pluripotent stem cells. Gafni O; Weinberger L; Mansour AA; Manor YS; Chomsky E; Ben-Yosef D; Kalma Y; Viukov S; Maza I; Zviran A; Rais Y; Shipony Z; Mukamel Z; Krupalnik V; Zerbib M; Geula S; Caspi I; Schneir D; Shwartz T; Gilad S; Amann-Zalcenstein D; Benjamin S; Amit I; Tanay A; Massarwa R; Novershtern N; Hanna JH Nature; 2013 Dec; 504(7479):282-6. PubMed ID: 24172903 [TBL] [Abstract][Full Text] [Related]
6. Disclosing the crosstalk among DNA methylation, transcription factors, and histone marks in human pluripotent cells through discovery of DNA methylation motifs. Luu PL; Schöler HR; Araúzo-Bravo MJ Genome Res; 2013 Dec; 23(12):2013-29. PubMed ID: 24149073 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells. Hewitt KJ; Shamis Y; Hayman RB; Margvelashvili M; Dong S; Carlson MW; Garlick JA PLoS One; 2011 Feb; 6(2):e17128. PubMed ID: 21386890 [TBL] [Abstract][Full Text] [Related]
8. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Bhutani N; Brady JJ; Damian M; Sacco A; Corbel SY; Blau HM Nature; 2010 Feb; 463(7284):1042-7. PubMed ID: 20027182 [TBL] [Abstract][Full Text] [Related]
9. Gingival fibroblasts as a promising source of induced pluripotent stem cells. Egusa H; Okita K; Kayashima H; Yu G; Fukuyasu S; Saeki M; Matsumoto T; Yamanaka S; Yatani H PLoS One; 2010 Sep; 5(9):e12743. PubMed ID: 20856871 [TBL] [Abstract][Full Text] [Related]
10. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide screen of promoter methylation analysis of ES cells and ES derived epidermal-like cells. Zhang RL; Meng JX; Liu CX; Zhang LL; Han D; Cai JJ; Wen AM Cell Biochem Funct; 2015 Aug; 33(6):398-406. PubMed ID: 26373683 [TBL] [Abstract][Full Text] [Related]
12. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins. Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118 [TBL] [Abstract][Full Text] [Related]
13. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines. Okada M; Yoneda Y Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232 [TBL] [Abstract][Full Text] [Related]
14. Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes. Christodoulou C; Longmire TA; Shen SS; Bourdon A; Sommer CA; Gadue P; Spira A; Gouon-Evans V; Murphy GJ; Mostoslavsky G; Kotton DN J Clin Invest; 2011 Jun; 121(6):2313-25. PubMed ID: 21537085 [TBL] [Abstract][Full Text] [Related]
15. Comparative epigenetic evaluation of human embryonic stem and induced pluripotent cells. Favaedi R; Shahhoseini M; Pakzad M; Mollamohammadi S; Baharvand H Int J Dev Biol; 2016; 60(4-6):103-10. PubMed ID: 27389983 [TBL] [Abstract][Full Text] [Related]
17. Comparison of gene-specific DNA methylation patterns in equine induced pluripotent stem cell lines with cells derived from equine adult and fetal tissues. Hackett CH; Greve L; Novakofski KD; Fortier LA Stem Cells Dev; 2012 Jul; 21(10):1803-11. PubMed ID: 21988203 [TBL] [Abstract][Full Text] [Related]
18. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626 [TBL] [Abstract][Full Text] [Related]
19. Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. Tsubooka N; Ichisaka T; Okita K; Takahashi K; Nakagawa M; Yamanaka S Genes Cells; 2009 Jun; 14(6):683-94. PubMed ID: 19476507 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation dynamics in human induced pluripotent stem cells over time. Nishino K; Toyoda M; Yamazaki-Inoue M; Fukawatase Y; Chikazawa E; Sakaguchi H; Akutsu H; Umezawa A PLoS Genet; 2011 May; 7(5):e1002085. PubMed ID: 21637780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]